NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free OM Stock Alerts $2.55 +0.09 (+3.66%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$2.41▼$2.6150-Day Range$1.94▼$3.7952-Week Range$1.92▼$24.13Volume769,560 shsAverage Volume1.03 million shsMarket Capitalization$131.84 millionP/E RatioN/ADividend YieldN/APrice Target$5.42 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Outset Medical alerts: Email Address Outset Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside112.4% Upside$5.42 Price TargetShort InterestBearish16.17% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.59Based on 2 Articles This WeekInsider TradingSelling Shares$69,521 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.28) to ($2.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.56 out of 5 starsMedical Sector655th out of 909 stocksElectromedical Equipment Industry11th out of 18 stocks 3.2 Analyst's Opinion Consensus RatingOutset Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageOutset Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted16.17% of the outstanding shares of Outset Medical have been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 8.2.Change versus previous monthShort interest in Outset Medical has recently decreased by 1.88%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OM. Previous Next 3.1 News and Social Media Coverage News SentimentOutset Medical has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Outset Medical this week, compared to 2 articles on an average week.Search Interest7 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.MarketBeat Follows4 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $69,521.00 in company stock.Percentage Held by InsidersOnly 3.50% of the stock of Outset Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($2.28) to ($2.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -0.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> About Outset Medical Stock (NASDAQ:OM)Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Read More OM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OM Stock News HeadlinesApril 20, 2024 | americanbankingnews.comHead to Head Survey: Endonovo Therapeutics (OTCMKTS:ENDV) & Outset Medical (NASDAQ:OM)April 19, 2024 | finance.yahoo.comOutset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024April 24, 2024 | Behind the Markets (Ad)Pentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...April 17, 2024 | finance.yahoo.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 17, 2024 | businesswire.comOutset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.April 15, 2024 | businesswire.comOutset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient CareApril 9, 2024 | investing.comOutset Medical shares get Buy rating from BTIGApril 8, 2024 | msn.comBuy Rating And Bullish Price Target Sends Small Cap SoaringApril 24, 2024 | Behind the Markets (Ad)Pentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...April 8, 2024 | markets.businessinsider.comOutset Medical: Overcoming Challenges with Strong Market Potential and Recurring Revenue GrowthMarch 18, 2024 | msn.comCare Plan Your Doctor Would Usually Recommend For Acute Otitis MediaMarch 13, 2024 | businesswire.comOutset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of DirectorsMarch 6, 2024 | wsj.comWhy Dialysis Stocks Are up TodayFebruary 26, 2024 | businesswire.comOutset Medical to Present at the 44th Annual TD Cowen Health Care ConferenceFebruary 23, 2024 | finance.yahoo.comOutset Medical Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 22, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Outset Medical (OM)February 22, 2024 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call TranscriptFebruary 22, 2024 | finance.yahoo.comQ4 2023 Outset Medical Inc Earnings CallFebruary 21, 2024 | msn.comOutset Medical beats top-line and bottom-line estimates; reaffirms FY24 outlookFebruary 21, 2024 | finance.yahoo.comOutset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 21, 2024 | finance.yahoo.comOutset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 ResultsFebruary 21, 2024 | businesswire.comOutset Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | msn.comOutset Medical Q4 2023 Earnings PreviewFebruary 17, 2024 | finance.yahoo.comOM Mar 2024 4.000 putFebruary 14, 2024 | investing.comOutset Medical Inc (OM)February 5, 2024 | finance.yahoo.comOutset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?February 5, 2024 | finance.yahoo.comOutset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024See More Headlines Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/21/2024Today4/24/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:OM CUSIPN/A CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees480Year FoundedN/APrice Target and Rating Average Stock Price Target$5.42 High Stock Price Target$6.00 Low Stock Price Target$3.00 Potential Upside/Downside+112.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-172,800,000.00 Net Margins-132.54% Pretax Margin-132.14% Return on Equity-102.50% Return on Assets-52.42% Debt Debt-to-Equity Ratio1.06 Current Ratio5.26 Quick Ratio4.37 Sales & Book Value Annual Sales$130.38 million Price / Sales1.01 Cash FlowN/A Price / Cash FlowN/A Book Value$2.45 per share Price / Book1.04Miscellaneous Outstanding Shares51,700,000Free Float49,892,000Market Cap$131.84 million OptionableNot Optionable Beta1.99 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Leslie L. Trigg (Age 53)President, CEO & Chairman Comp: $1.22MMr. Nabeel Ahmed (Age 48)Chief Financial Officer Comp: $654.74kMr. John L. Brottem (Age 49)General Counsel & Secretary Comp: $594.15kMr. Marc Nash (Age 35)Senior Vice President of Operations and R&D Mr. Jean-Olivier Racine (Age 42)Chief Technology Officer Comp: $540.93kMr. James S. MazzolaHead of Investor RelationsNicole ShannonDirector of Marketing CommunicationsDr. Michael Aragon M.D.Chief Medical OfficerMr. Mark Gordon M.S. (Age 67)Chief Regulatory & Quality Officer More ExecutivesKey CompetitorsElectromedNYSE:ELMDFONARNASDAQ:FONRVivani MedicalNASDAQ:VANISemler ScientificNASDAQ:SMLRHyperfineNASDAQ:HYPRView All CompetitorsInsiders & InstitutionsAssenagon Asset Management S.A.Sold 76,026 shares on 4/24/2024Ownership: 1.828%Griffin Asset Management Inc.Bought 5,300 shares on 4/17/2024Ownership: 0.189%Marc NashSold 2,391 sharesTotal: $5,092.83 ($2.13/share)Mubadala Investment Co PJSCBought 1,440,601 shares on 3/5/2024Ownership: 2.852%GSA Capital Partners LLPBought 429,851 shares on 2/16/2024Ownership: 1.024%View All Insider TransactionsView All Institutional Transactions OM Stock Analysis - Frequently Asked Questions Should I buy or sell Outset Medical stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares. View OM analyst ratings or view top-rated stocks. What is Outset Medical's stock price target for 2024? 6 Wall Street analysts have issued 12 month target prices for Outset Medical's shares. Their OM share price targets range from $3.00 to $6.00. On average, they predict the company's stock price to reach $5.42 in the next twelve months. This suggests a possible upside of 112.4% from the stock's current price. View analysts price targets for OM or view top-rated stocks among Wall Street analysts. How have OM shares performed in 2024? Outset Medical's stock was trading at $5.41 on January 1st, 2024. Since then, OM shares have decreased by 52.9% and is now trading at $2.55. View the best growth stocks for 2024 here. When is Outset Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our OM earnings forecast. How can I listen to Outset Medical's earnings call? Outset Medical will be holding an earnings conference call on Wednesday, May 8th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) released its earnings results on Wednesday, February, 21st. The company reported ($0.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.74) by $0.03. The company earned $30.51 million during the quarter, compared to analysts' expectations of $30.40 million. Outset Medical had a negative net margin of 132.54% and a negative trailing twelve-month return on equity of 102.50%. What ETFs hold Outset Medical's stock? ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT).Procure Disaster Recovery Strategy ETF (FEMA). What guidance has Outset Medical issued on next quarter's earnings? Outset Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Outset Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (1.83%) and Griffin Asset Management Inc. (0.19%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter and Steven S Williamson. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
